humans |
21 |
medical sciences |
20 |
female |
19 |
male |
19 |
stroke |
19 |
adiponectin |
17 |
atrial fibrillation |
17 |
adult |
16 |
middle aged |
16 |
hypertension |
14 |
blood pressure |
13 |
myocardial infarction |
13 |
neuromyelitis optica |
13 |
recurrence |
13 |
alzheimer's disease |
12 |
adolescent |
11 |
intracranial hemorrhage |
11 |
aged |
10 |
anisotropy |
10 |
gastrointestinal haemorrhage |
10 |
intracerebral hemorrhage |
10 |
ischemic stroke |
10 |
multiple sclerosis |
10 |
mutation |
10 |
time in therapeutic range |
10 |
age factors |
9 |
endothelial function |
9 |
family health |
9 |
garlic |
9 |
treatment outcome |
9 |
type 2 diabetes mellitus |
9 |
aerosolised |
8 |
ampk |
8 |
anosmia |
8 |
aβ |
8 |
blood pressure variability |
8 |
brain - pathology |
8 |
cardiovascular and cerebrovascular diseases |
8 |
cha2ds2-vasc |
8 |
chads2 |
8 |
classical multiple sclerosis |
8 |
cognitive impairments |
8 |
follow-up studies |
8 |
functional brain network |
8 |
insulin resistance |
8 |
long covid |
8 |
mortality |
8 |
olfactory dysfunction |
8 |
olfactory training |
8 |
resting-state fmri |
8 |
risk factors |
8 |
smell loss |
8 |
superoxide dismutase - genetics |
8 |
vascular markers |
8 |
vascular markers of atherosclerosis |
8 |
vitamin a |
8 |
young adult |
8 |
5' untranslated regions - genetics |
7 |
alzheimer’s disease |
7 |
antiplatelet medication |
7 |
aquaporin-4 autoantibodies |
7 |
asian continental ancestry group - ethnology |
7 |
cha2ds2-vasc score |
7 |
chads2 score |
7 |
charcot-marie-tooth |
7 |
charcot-marie-tooth disease - genetics - pathology - physiopathology |
7 |
child |
7 |
chinese |
7 |
connexins - genetics |
7 |
cutoff |
7 |
dna mutational analysis |
7 |
electromyography |
7 |
genetic diseases, x-linked - genetics |
7 |
gjb1 (connexin32) |
7 |
hematoma location |
7 |
intracranial hemorrhages |
7 |
lacunar infarct |
7 |
microscopy, electron, transmission |
7 |
neural conduction - genetics - physiology |
7 |
neuroinflammation |
7 |
neuropathy |
7 |
non-coding region |
7 |
peripheral nerves - pathology - physiopathology - ultrastructure |
7 |
point mutation - genetics |
7 |
prognosis |
7 |
sequence analysis |
7 |
stroke outcome |
7 |
als |
6 |
amyotrophic lateral sclerosis - enzymology - genetics - pathology |
6 |
amyotrophic lateral sclerosis - genetics |
6 |
antiplatelet agents |
6 |
asian continental ancestry group |
6 |
aspirin - administration & dosage - adverse effects |
6 |
ciliary neurotrophic factor - genetics |
6 |
cntf |
6 |
coronary artery disease |
6 |
diabetes |
6 |
diffusion magnetic resonance imaging - methods |
6 |
dna mutational analysis - methods |
6 |
dti |
6 |
exons - genetics |
6 |
familial |
6 |
familial amyotrophic lateral sclerosis |
6 |
glycaemia |
6 |
has-bled score |
6 |
hba1c variability |
6 |
ich volume |
6 |
image processing, computer-assisted |
6 |
intracranial hemorrhages - drug therapy - physiopathology - surgery |
6 |
intraventricular extension |
6 |
isoleucine - genetics |
6 |
mediterranean-style diet |
6 |
mutations |
6 |
neurological deterioration |
6 |
neuromyelitis optica spectrum disorders |
6 |
nonsymptomatic |
6 |
pedigree |
6 |
phenotype |
6 |
platelet aggregation inhibitors - administration & dosage - adverse effects |
6 |
registries |
6 |
reverse transcriptase polymerase chain reaction - methods |
6 |
sod1 |
6 |
sod1 mutation |
6 |
spinal cord - pathology |
6 |
statistics, nonparametric |
6 |
stroke/prevention |
6 |
threonine - genetics |
6 |
vascular endothelial growth factor a - genetics |
6 |
vegf |
6 |
visit-to-visit blood pressure variability |
6 |
warfarin |
6 |
warfarin-associated ich |
6 |
animals |
5 |
autoantibodies - blood |
5 |
autoimmune encephalitis |
5 |
beta deposition |
5 |
cervical spinal cord |
5 |
dentate gyrus |
5 |
diffusion tensor imaging |
5 |
diffusion tensor imaging - methods |
5 |
follow-up |
5 |
free radicals |
5 |
hong kong |
5 |
insulin-resistance |
5 |
limbic encephalitis |
5 |
mitochondrial dysfunction |
5 |
neuromyelitis optica - diagnosis - pathology |
5 |
neuroprotection |
5 |
optic neuritis |
5 |
oxidative stress |
5 |
paraneoplastic syndrome |
5 |
possible involvement |
5 |
retrospective studies |
5 |
secondary prevention |
5 |
survivors |
5 |
ucp4 |
5 |
uncoupling proteins |
5 |
1-methyl-4-phenylpyridinium - metabolism |
4 |
1-methyl-4-phenylpyridinium - toxicity |
4 |
abbreviated metal test |
4 |
acquired myasthenia gravis |
4 |
adenosine triphosphate - genetics - metabolism |
4 |
adenosine triphosphate - metabolism |
4 |
adult cardiology |
4 |
aged, 80 and over |
4 |
alzheimers disease assessment scale cognitive subscale |
4 |
amyloid beta protein |
4 |
amyotrophic lateral sclerosis |
4 |
angiography, digital subtraction |
4 |
antibodies - immunology |
4 |
apoptosis |
4 |
aquaporin 4 - biosynthesis - genetics |
4 |
aquaporin 4 - immunology |
4 |
aquaporin-4 water channel |
4 |
atp |
4 |
autoimmune |
4 |
autoimmune diseases of the nervous system - immunology |
4 |
azathioprine |
4 |
benign paroxysmal positional vertigo |
4 |
bronchial epithelium |
4 |
cell fractionation |
4 |
cell line |
4 |
cell line, tumor |
4 |
cell survival |
4 |
cerebellar hemorrhages |
4 |
cerebrovascular circulation |
4 |
cervical vertebrae |
4 |
chi-square distribution |
4 |
clinical outcome |
4 |
cloning, molecular |
4 |
compute tomography |
4 |
cross-sectional studies |
4 |
cytoprotection |
4 |
demyelinating diseases - immunology |
4 |
dermatomyositis - etiology - therapy |
4 |
diffusional kurtosis imaging |
4 |
dopamine |
4 |
dopamine - metabolism |
4 |
dopamine - pharmacology |
4 |
endothelin-1 |
4 |
enzyme linked immunosorbent assay |
4 |
epidemiologic studies |
4 |
epidemiology |
4 |
expand disability status scale |
4 |
expanded disability status scale score |
4 |
experimental allergic encephalomyelitis |
4 |
fever of unknown origin - microbiology - radiography |
4 |
fluorescent antibody technique, indirect |
4 |
gene delivery |
4 |
glycolysis - drug effects |
4 |
herbicides - toxicity |
4 |
hong kong - epidemiology |
4 |
hong kong chinese |
4 |
idiopathic inflammatory demyelinating disorders |
4 |
idiopathic relapsing transverse myelitis |
4 |
immunization |
4 |
immunodominant epitopes - chemistry - immunology |
4 |
immunoglobulin g - blood |
4 |
immunosuppressant therapy |
4 |
incidence |
4 |
inflammatory demyelinating disorders |
4 |
ion channels - genetics - metabolism |
4 |
ion channels - genetics - physiology |
4 |
leptin - pharmacology |
4 |
logistic models |
4 |
long-term outcome |
4 |
longitudinally extensive transverse myelitis |
4 |
lung function |
4 |
lymphatic metastasis |
4 |
magnetic resonance imaging - methods |
4 |
membrane potential, mitochondrial |
4 |
membrane potential, mitochondrial - drug effects |
4 |
membrane transport proteins - genetics - immunology - metabolism |
4 |
membrane transport proteins - genetics - metabolism |
4 |
minimally conscious state |
4 |
mitochondria |
4 |
mitochondria - drug effects - metabolism |
4 |
mitochondria - genetics - immunology - metabolism |
4 |
mitochondrial membrane potential |
4 |
mitochondrial proteins - genetics - metabolism |
4 |
mitochondrial proteins - genetics - physiology |
4 |
motor neuron disease |
4 |
motor neuron disease - diagnosis - epidemiology |
4 |
motor neuron disease - etiology - therapy |
4 |
mpp + |
4 |
mpp+ |
4 |
multiple sclerosis - immunology |
4 |
myasthenia gravis |
4 |
myasthenia gravis - immunology - metabolism - pathology |
4 |
myelitis, transverse - immunology |
4 |
myositis - etiology - therapy |
4 |
nasopharyngeal carcinoma |
4 |
nasopharyngeal neoplasms - complications |
4 |
neoplasm recurrence, local - complications - therapy |
4 |
nerve tissue proteins - genetics - metabolism |
4 |
neuromyelitis optica - immunology |
4 |
neuromyelitis optica-igg |
4 |
neurons - drug effects - metabolism - pathology |
4 |
neurons - immunology - metabolism - pathology |
4 |
neuroprotective agents - pharmacology |
4 |
nicotine |
4 |
nicotinic acetylcholine receptor |
4 |
nlrp3 |
4 |
normal-appearing brain tissues |
4 |
optic neuritis - immunology |
4 |
oxidative phosphorylation |
4 |
oxidative stress - drug effects |
4 |
paraneoplastic inflammatory myopathy |
4 |
paraneoplastic motor neuropathy |
4 |
paraneoplastic neurological disorders |
4 |
paraneoplastic syndromes - etiology - therapy |
4 |
parkinson disease |
4 |
peptides - administration & dosage - chemical synthesis |
4 |
pregnancy |
4 |
pregnancy complications, infectious - etiology - radiography |
4 |
prevalence |
4 |
proinflammatory cytokines |
4 |
protein blood level |
4 |
psychiatry and neurology |
4 |
quantitative polymerase chain reaction |
4 |
relapsing remitting multiple sclerosis |
4 |
rna, small interfering |
4 |
secondary progression multiple sclerosis |
4 |
sex factors |
4 |
sheep |
4 |
standard deviation |
4 |
superoxides - metabolism |
4 |
telemedicine |
4 |
th1 cells |
4 |
th17 cells |
4 |
thymoma |
4 |
thymoma - immunology - metabolism - pathology |
4 |
thymus neoplasms - immunology - metabolism - pathology |
4 |
tomography, x-ray computed - methods |
4 |
transgenes - genetics |
4 |
tuberculoma - complications - radiography |
4 |
tuberculosis, meningeal - complications - radiography |
4 |
ucp |
4 |
β-interferon |
4 |
acetylcholine receptor autoantibodies |
3 |
acute disease |
3 |
acute transverse myelitis |
3 |
affective symptoms - etiology |
3 |
age of onset |
3 |
anti-coagulation |
3 |
anti-inflammatory agents - therapeutic use |
3 |
anticoagulants - therapeutic use |
3 |
antihypertensive agents - adverse effects - pharmacology - therapeutic use |
3 |
antioxidants - metabolism |
3 |
antiparkinson agents - therapeutic use |
3 |
antiviral agents - therapeutic use |
3 |
aquaporin 4 - antagonists and inhibitors - deficiency - genetics - immunology |
3 |
asian continental ancestry group - statistics & numerical data |
3 |
astrocyte activation |
3 |
astrocytes - immunology - metabolism - pathology |
3 |
autoantibodies - analysis - immunology |
3 |
autoantibodies - toxicity |
3 |
autoimmunity |
3 |
bath-related headache |
3 |
baths - adverse effects |
3 |
biological evolution |
3 |
brain - blood supply |
3 |
brain - pathology - virology |
3 |
brain - physiology |
3 |
brain edema - etiology |
3 |
brain ischemia - etiology - physiopathology |
3 |
brainstem |
3 |
brainstem atrophy |
3 |
brainstem regional volume |
3 |
bromocriptine - therapeutic use |
3 |
bronchial epithelial cells |
3 |
c-rel |
3 |
carotid artery, internal - radiography |
3 |
cerebral angiography |
3 |
cerebral arteries - metabolism |
3 |
cerebral haemorrhage |
3 |
cerebral infarction |
3 |
cerebral infarction - etiology - radiography |
3 |
cerebral venous thrombosis |
3 |
chelating agents - therapeutic use |
3 |
child, preschool |
3 |
chrna7 |
3 |
cigarette smoke |
3 |
cognition - physiology |
3 |
complement activation |
3 |
confusion - etiology |
3 |
corticosteroid |
3 |
demyelinating autoimmune diseases, cns - immunology |
3 |
demyelinating diseases - diagnosis - etiology - therapy |
3 |
demyelinating diseases - immunology - metabolism - pathology |
3 |
demyelinating disorders |
3 |
depression |
3 |
depressive disorder - complications - pathology - psychology |
3 |
dexamethasone - therapeutic use |
3 |
diabetes complications - etiology |
3 |
diagnosis, differential |
3 |
diffusion magnetic resonance imaging |
3 |
digital subtraction angiography |
3 |
disability |
3 |
disease progression |
3 |
early-onset myasthneia gravis |
3 |
encephalitis |
3 |
encephalitis, herpes simplex - pathology |
3 |
energy homeostasis |
3 |
environment |
3 |
epilepsy, generalized - etiology |
3 |
equipment design |
3 |
european continental ancestry group - genetics |
3 |
fatal outcome |
3 |
fever - etiology |
3 |
fluorescent antibody technique, indirect - methods |
3 |
frontal lobe - pathology |
3 |
gene expression regulation, developmental - genetics |
3 |
guillain-barre syndrome |
3 |
guillain-barré syndrome |
3 |
headache |
3 |
headache - diagnosis - etiology - therapy |
3 |
headache - etiology |
3 |
heparin, low-molecular-weight - therapeutic use |
3 |
hepatitis e |
3 |
hepatitis e virus |
3 |
hepatolenticular degeneration - complications - pathology - psychology |
3 |
hypertension - complications - drug therapy |
3 |
idiopathic inflammatory |
3 |
idiopathic transverse myelitis |
3 |
infarction, middle cerebral artery - etiology - physiopathology - radiography - surgery |
3 |
infarction, posterior cerebral artery - etiology - physiopathology |
3 |
intelligence - genetics |
3 |
intracranial arteriosclerosis - complications |
3 |
intracranial arteriosclerosis - genetics |
3 |
intracranial hemorrhages - etiology - pathology - physiopathology |
3 |
intracranial thrombosis - complications |
3 |
intracranial thrombosis - complications - pathology - physiopathology |
3 |
large artery infarct |
3 |
late-onset myasthenia gravis |
3 |
life style |
3 |
lung cancer |
3 |
magnetic resonance imaging |
3 |
magnetic resonance imaging (mri) |
3 |
microglia |
3 |
middle cerebral artery - radiography |
3 |
models, biological |
3 |
motor endplate - metabolism |
3 |
mouse |
3 |
multiple sclerosis (ms) |
3 |
muscle, skeletal - metabolism |
3 |
myasthenia gravis - diagnosis - epidemiology - therapy |
3 |
myelin |
3 |
myelin sheath - pathology |
3 |
myelitis, transverse - complications - diagnosis - physiopathology - therapy |
3 |
myelitis, transverse - diagnosis - etiology - therapy |
3 |
myopia - genetics |
3 |
nephrotic syndrome - complications |
3 |
nervous system |
3 |
neurodegeneration |
3 |
neuromyelitis optica - immunology - metabolism - pathology |
3 |
neuromyelitis optica spectrum disorders (nmosd) |
3 |
nonthymoma-generalized myasthenia gravis |
3 |
nuclear factor κb |
3 |
nuclear factor-κb |
3 |
oriental female |
3 |
parkinson's disease |
3 |
parkinsonian disorders - complications - pathology - psychology |
3 |
parkinsonism |
3 |
parkinsons disease |
3 |
pd-l1 |
3 |
penicillamine |
3 |
penicillamine - therapeutic use |
3 |
plasmapheresis |
3 |
porcine liver |
3 |
promoter |
3 |
psychiatry and neurology medical sciences |
3 |
pulmonary edema - etiology |
3 |
radiography, interventional |
3 |
receptors, nicotinic - immunology |
3 |
relayed nuclear overhauser effect (rnoe) |
3 |
seizures - etiology |
3 |
selection, genetic |
3 |
severity of illness index |
3 |
spinal cord |
3 |
striated muscle autoantibodies |
3 |
substance abuse, intravenous - complications |
3 |
suicide, attempted |
3 |
surgery |
3 |
temporal lobe - pathology |
3 |
thrombectomy - instrumentation - methods |
3 |
thunderclap headache |
3 |
tomography, x-ray computed |
3 |
transcription regulation |
3 |
trientine - therapeutic use |
3 |
trientine hydrochloride |
3 |
triggering agents |
3 |
trihexyphenidyl - therapeutic use |
3 |
tuberculosis, meningeal - complications - drug therapy - radiography |
3 |
tuberculous meningitis |
3 |
uncoupling protein |
3 |
uncoupling protein 4 |
3 |
vasoconstriction |
3 |
venous thrombosis - complications |
3 |
venous thrombosis - complications - pathology - physiopathology |
3 |
viral encephalitis |
3 |
vision disorders - etiology |
3 |
warfarin - therapeutic use |
3 |
wernicke encephalopathy - complications - diagnosis |
3 |
wilson's disease |
3 |
amyloid-β |
2 |
antibodies, viral - analysis |
2 |
antitubercular agents - therapeutic use |
2 |
aquaporin 4 |
2 |
aquaporin-4 |
2 |
arterial spin labeling |
2 |
astrocyte |
2 |
autoimmune diseases |
2 |
axonal damage |
2 |
biologics |
2 |
blood brain barrier leakage |
2 |
carcinoma, hepatocellular - diagnosis - pathology |
2 |
cerebral amyloid angiopathy |
2 |
cerebral blood flow |
2 |
cerebrospinal fluid |
2 |
cerebrovascular disorders - etiology - physiopathology - prevention & control - therapy |
2 |
cidp |
2 |
circadian rhythm |
2 |
circadian rhythm - physiology |
2 |
complications |
2 |
cryptococcosis |
2 |
data collection |
2 |
dementia |
2 |
demyelination |
2 |
ectopic lymphoid structures |
2 |
encephalitis - diagnosis - pathology |
2 |
encephalocele |
2 |
endothelium inflammation |
2 |
epilepsy |
2 |
experimental autoimmune encephalomyelitis |
2 |
germinal center |
2 |
growing fracture |
2 |
head injury |
2 |
hematology |
2 |
hiv - immunology |
2 |
hong kong - ethnology |
2 |
hospitals |
2 |
hydrocephalus - cerebrospinal fluid - drug therapy - etiology |
2 |
hypertension, malignant - diagnosis |
2 |
intracerebral haemorrhage |
2 |
intracranial hemorrhages - diagnosis - pathology |
2 |
intracranial hypertension - microbiology |
2 |
ischaemic stroke |
2 |
ischemic attack, transient - mortality - physiopathology |
2 |
knowledge |
2 |
meningitis, cryptococcal - complications - diagnosis - drug therapy |
2 |
miller fisher syndrome - complications - therapy |
2 |
myasthenia gravis - etiology |
2 |
mycobacterium tuberculosis - isolation & purification |
2 |
nervous system diseases - complications |
2 |
neuromyelitis optica - classification - pathology |
2 |
neuromyelitis optica spectrum disorder |
2 |
pparγ |
2 |
prospective studies |
2 |
rorγt |
2 |
sirt1 |
2 |
snp |
2 |
stroke - complications |
2 |
stroke - mortality - physiopathology |
2 |
stroke onset |
2 |
subjective cognitive decline |
2 |
survey |
2 |
tag-1 |
2 |
th17 cell |
2 |
time factors |
2 |
transient ischaemic attack |
2 |
transplant |
2 |
tuberculosis, meningeal - cerebrospinal fluid - complications - drug therapy |
2 |
acetylcholine receptor |
1 |
achr antibody |
1 |
adult-acquired myasthenia gravis |
1 |
antibodies, antinuclear - blood |
1 |
anticholesteremic agents - adverse effects |
1 |
aqp4-igg |
1 |
aquaporin-4 autoimmunity |
1 |
autoantibodies |
1 |
autoantibody evaluation |
1 |
autoimmunity - immunology |
1 |
b lymphocytes |
1 |
beta-interferons (乙型干擾素) |
1 |
carcinoma, small cell - blood - immunology |
1 |
cyclosporine - adverse effects |
1 |
cytomegalovirus infections - complications |
1 |
ganglion cell layer |
1 |
hepatitis b -- periodicals. |
1 |
heptanoic acids - adverse effects |
1 |
immunomodulation |
1 |
immunosuppressive agents - adverse effects |
1 |
interferon -- periodicals. |
1 |
lung neoplasms - blood - immunology |
1 |
memantine |
1 |
mesenchymal stem cells |
1 |
multiple sclerosis -- periodicals. |
1 |
muscle |
1 |
musk antibody |
1 |
myasthenia gravis. |
1 |
natalizumab |
1 |
neural |
1 |
optical coherence tomography |
1 |
paraneoplastic syndromes, nervous system - blood - immunology |
1 |
regulatory b cells |
1 |
regulatory t cells |
1 |
relapsing-remitting multiple sclerosis (復發緩解型多發性硬化) |
1 |
retinal nerve fiber layer |
1 |
seronegative myasthenia gravis |
1 |
t lymphocytes |
1 |
water channel |
1 |